This post was originally published on this site
https://i-invdn-com.investing.com/trkd-images/LYNXMPEJ650TF_L.jpg
The company now expects adjusted profit between $10.57 and $10.97 per share, compared with $10.72 to $11.12 it previously expected.
Analysts on average were expecting full-year earnings of $10.97 per share, according to Refinitiv IBES data.
AbbVie (NYSE:ABBV) also trimmed adjusted profit for the second quarter by $0.15 per share and expects to post adjusted profit of $2.75 to $2.85 per share.
The company is scheduled to report second-quarter results on July 27.
